![Charles Berkman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Berkman
Direttore/Membro del Consiglio presso
PFENEX INC.
Patrimonio netto: 1 M $ in data 31/05/2026
Profilo
Charles Stuart Berkman is Secretary, Director, Senior VP & General Counsel at Pelican, Inc. since 2020.
Holds positions as Secretary & Director at Ligand UK Group Ltd., Secretary & Vice President at Metabasis Therapeutics, Inc. since 2010, Secretary & Chief Legal Officer at OmniAb Operations, Inc. since 2022, and Secretary & Chief Legal Officer at OmniAb, Inc. since 2022.
Formerly Secretary & Director at Ligand UK Research Ltd. and Ligand UK Ltd. from 2018 to 2022.
Served as Secretary, Senior Vice President & General Counsel at Ligand Pharmaceuticals, Inc. from 2001 to 2022.
Worked as Attorney at Baker & McKenzie LLP (Illinois) from 2000 to 2001 and at Lyon & Lyon, Inc. from 1993 to 2000.
Completed undergraduate studies at The University of Texas at Austin and graduate studies at The University of Texas School of Law.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OMNIAB, INC. 0,28% | 23/04/2026 | 399.085 ( 0,28% ) | 1 M $ | 31/05/2026 |
Posizioni attive di Charles Berkman
| Società | Posizione | Inizio |
|---|---|---|
| PFENEX INC. | Direttore/Membro del Consiglio | 01/10/2020 |
| OMNIAB, INC. | Consigliere Generale | 01/03/2022 |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Segretario Aziendale | 29/01/2010 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | 12/10/2018 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Consigliere Generale | 01/03/2022 |
Precedenti posizioni note di Charles Berkman
| Società | Posizione | Fine |
|---|---|---|
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore/Membro del Consiglio | 19/03/2024 |
| LIGAND PHARMACEUTICALS INCORPORATED | Consigliere Generale | 01/11/2022 |
| VERNALIS | Direttore/Membro del Consiglio | 01/11/2022 |
Baker & McKenzie LLP (Illinois)
 Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/11/2001 |
| ░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Charles Berkman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Baker & McKenzie LLP (Illinois)
Baker & McKenzie LLP (Illinois) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Lyon & Lyon, Inc.
 Lyon & Lyon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
The University of Texas School of Law
 The University of Texas School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
